Table 7.
Five-Year Total, Annual Average Totala, and Average Annual Age-Adjusted Incidence Ratesb with 95% Confidence Intervals for Selected Non-Malignant Histopathologies by Sex, Age Groups, Race, and Hispanic Ethnicity, Histopathology, and Age at Diagnosis, CBTRUS Statistical Report: US Cancer Statistics – NPCR and SEER, 2016-2020
| Group | Vestibular Schwannomac | Pituitary Adenomad | WHO Grade I Meningiomae | WHO Grade II Meningiomaf | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 5-Year Total | Annual Average | Rate (95% CI) | 5-Year Total | Annual Average | Rate (95% CI) | 5-Year Total | Annual Average | Rate (95% CI) | 5-Year Total | Annual Average | Rate (95% CI) | |
| Sex | ||||||||||||
| Male | 13,107 | 2,621 | 1.48 (1.45-1.50) | 30,296 | 6,059 | 3.51 (3.47-3.55) | 20,158 | 4,032 | 2.29 (2.25-2.32) | 4,144 | 829 | 0.47 (0.46-0.49) |
| Female | 14,590 | 2,918 | 1.52 (1.49-1.55) | 38,364 | 7,673 | 4.51 (4.47-4.56) | 54,441 | 10,888 | 5.49 (5.45-5.54) | 5,843 | 1,169 | 0.61 (0.60-0.63) |
| Age Groups | ||||||||||||
| 0-14 years | 198 | 40 | 0.07 (0.06-0.08) | 989 | 198 | 0.33 (0.31-0.35) | 110 | 22 | 0.04 (0.03-0.04) | 83 | 17 | 0.03 (0.02-0.03) |
| 15-39 years | 3,632 | 726 | 0.69 (0.67-0.71) | 19,705 | 3,941 | 3.64 (3.59-3.69) | 5,158 | 1,032 | 1.01 (0.98-1.04) | 1,124 | 225 | 0.22 (0.20-0.23) |
| 40-64 years | 14,070 | 2,814 | 2.53 (2.49-2.58) | 28,540 | 5,708 | 5.47 (5.40-5.54) | 32,676 | 6,535 | 5.86 (5.79-5.92) | 4,657 | 931 | 0.85 (0.82-0.87) |
| 65+ years | 9,797 | 1,959 | 3.71 (3.63-3.78) | 19,426 | 3,885 | 7.49 (7.39-7.60) | 36,655 | 7,331 | 14.37 (14.22-14.52) | 4,123 | 825 | 1.60 (1.55-1.65) |
| Race | ||||||||||||
| White | 23,592 | 4,718 | 1.58 (1.56-1.60) | 48,528 | 9,706 | 3.56 (3.52-3.59) | 59,793 | 11,959 | 3.88 (3.85-3.91) | 7,578 | 1,516 | 0.51 (0.50-0.52) |
| Black | 1,602 | 320 | 0.72 (0.68-0.75) | 14,032 | 2,806 | 6.38 (6.28-6.49) | 9,715 | 1,943 | 4.51 (4.42-4.61) | 1,591 | 318 | 0.71 (0.68-0.75) |
| American Indian/Alaska Native | 163 | 33 | 0.75 (0.63-0.87) | 608 | 122 | 2.78 (2.55-3.02) | 524 | 105 | 2.69 (2.46-2.94) | 56 | 11 | 0.29 (0.22-0.38) |
| Asian or Pacific Islander | 1,373 | 275 | 1.23 (1.16-1.29) | 2,932 | 586 | 2.67 (2.58-2.77) | 2,745 | 549 | 2.56 (2.46-2.66) | 506 | 101 | 0.47 (0.43-0.51) |
| Ethnicity | ||||||||||||
| Non-Hispanic | 25,235 | 5,047 | 1.58 (1.56-1.60) | 57,030 | 11,406 | 3.89 (3.86-3.92) | 67,178 | 13,436 | 4.06 (4.03-4.09) | 8,946 | 1,789 | 0.56 (0.55-0.57) |
| Hispanic | 2,412 | 482 | 0.99 (0.95-1.03) | 11,515 | 2,303 | 4.45 (4.37-4.54) | 7,248 | 1,450 | 3.27 (3.19-3.35) | 1,026 | 205 | 0.44 (0.42-0.47) |
| TOTAL | 27,697 | 5,539 | 1.50 (1.48-1.51) | 68,660 | 13,732 | 3.97 (3.94-4.00) | 74,599 | 14,920 | 3.96 (3.93-3.99) | 9,987 | 1,997 | 0.54 (0.53-0.55) |
aAnnual average cases are calculated by dividing the five-year total by five.
bRates are per 100,000 and are age-adjusted to the 2000 US standard population.
cICD-O-3 histopathology code 9560/0 and ICD-O-3 topography code C72.4 and C72.5.
dICD-O-3 histopathology code 8272/0 and ICD-O-3 topography code C75.1.
eICD-O-3 histopathology codes 9530/0, 9531/0, 9532/0, 9533/0, 9534/0, and 9537/0.
f ICD-O-3 histopathology codes 9530/1, 9531/1, 9532/1, 9533/1, 9534/1, 9537/1, 9538/1, and 9539/1.
- Counts and rates are not presented when fewer than 16 cases were reported for the specific category. The suppressed cases are included in the counts and rates for totals.
Abbreviations: CBTRUS, Central Brain Tumor Registry of the United States; US, United States; NPCR, National Program of Cancer Registries; SEER, Surveillance, Epidemiology, and End Results Program; WHO, World Health Organization; CI, confidence interval.